About the Course
This one-day course will provide a topical, clinically based overview of current issues in the multidisciplinary management of lung cancer, with an emphasis on recent advances and possible upcoming changes in standards of care.
Medical oncologists, radiation oncologists, pulmonologists, thoracic surgeons, physician assistants, nurses, and other health care providers with an interest in the management of lung cancer patients are encouraged to attend.
- Describe the role of low dose CT scans in screening high-risk individuals for lung cancer.
- Discuss the options for treatment in patients with medically high risk, early stage non-small cell lung cancer (NSCLC).
- Recognize current recommendations for routine molecular testing of patients with NSCLC, and the use of molecularly targeted therapies for defined subgroups of patients.
- Describe recommendations for the use of immune checkpoint inhibitors in the treatment of NSCLC patients, including the use of biomarkers to guide therapy.